Article Details
Retrieved on: 2025-05-22 15:22:36
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a partnership between Aptar Digital Health and AstraZeneca to use machine learning algorithms for early detection of chronic kidney disease (CKD) through retinal imaging. It highlights advancements in AI for non-invasive CKD assessment, aligning with the tags and key concept.
Article found on: www.medicaleconomics.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here